Scholar
Thomas Jaki
Google Scholar ID: hg4yUCoAAAAJ
Professor of Statistics, University of Regensburg and University of Cambridge
Pre-clinical Statistics
Early Phase Clinical Trials
Adaptive Designs
Follow
Homepage
↗
Google Scholar
↗
Citations & Impact
All-time
Citations
35,802
H-index
38
i10-index
120
Publications
20
Co-authors
182
list available
Publications
10 items
Introducing precision-weighted bias as a performance measure to inform the inclusion of adaptive designs in meta-analysis
2026
Cited
0
Operationalizing Allocation Probability Tests: Practical Guidance on Optimized Implementation for Power and Robustness
2026
Cited
0
Robust Bayesian Sequential Borrowing for Multi-Population Clinical Programmes
2026
Cited
0
Evaluating Predictive Modeling Strategies for Predicting Individual Treatment Effects in Precision Medicine
2026
Cited
0
Optimal weighted tests for replication studies and the two-trials rule
2025
Cited
0
A comparison of approaches to incorporate patient-selected and patient-ranked outcomes in clinical trials
2025
Cited
0
Using joint models in phase I dose-finding designs in oncology: considerations for frequentist approaches
2025
Cited
0
A Bayesian Additive Regression Trees Model for zero and one inflated data for Predicting Individual Treatment Effects in Alcohol Use Disorder Trials
2025
Cited
0
Load more
Co-authors
5 total
Pavel Mozgunov
Programme Leader Track at MRC Biostatistics Unit
Franz Koenig
Medical University of Vienna
James Wason
Newcastle University
Sofia S. Villar
Programme Leader at MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge
Dominic Magirr
Novartis
